{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:04:22Z","timestamp":1779869062954,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302604"],"award-info":[{"award-number":["82302604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC1607"],"award-info":[{"award-number":["2025ZNSFSC1607"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC0672"],"award-info":[{"award-number":["2025ZNSFSC0672"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u2018Qimingxing\u2019 Research Fund for Young Talents of West China Hospital of Sichuan University","award":["HXQMX0043"],"award-info":[{"award-number":["HXQMX0043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) and renal allograft failure represent escalating global health burdens characterized by progressive tissue remodeling. Although interstitial fibrosis and tubular atrophy (IF\/TA) are the primary determinants of long-term prognosis, their assessment currently relies on invasive kidney biopsies, which are unsuitable for longitudinal monitoring. Here, we identify soluble T-cell immunoglobulin and mucin domain-containing protein 3 (sTIM-3) as a robust, non-invasive indicator of renal histopathology and clinical outcomes. In this multi-cohort study, we enrolled 256 kidney transplant recipients (KTRs) with allograft biopsies, 442 native CKD patients with biopsy-confirmed diagnoses, and 44 KTRs with longitudinal follow-up. Pre-biopsy plasma sTIM-3 levels were quantified by ELISA and analyzed for associations with renal function, histopathological parameters, and adverse outcomes. We found that elevated sTIM-3 levels consistently correlated with impaired renal function across diverse etiologies. Notably, post-transplantation sTIM-3 exhibited slower decline kinetics compared to estimated glomerular filtration rate (eGFR), suggesting that it may reflect active tissue remodeling rather than transient functional shifts. Histopathological analyses revealed that sTIM-3 levels increased progressively with IF\/TA severity, demonstrating good discriminative capacity for moderate-to-severe fibrosis. Furthermore, in KTRs, elevated sTIM-3 predicted both allograft failure and rapid eGFR decline, with its prognostic value for the latter persisting after adjustment for eGFR and urine protein. Collectively, these findings establish sTIM-3 as a non-invasive biomarker reflecting tubulointerstitial fibrosis and adverse outcomes across diverse kidney disease settings, offering complementary information to conventional functional markers.<\/jats:p>","DOI":"10.1186\/s43556-026-00469-6","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:23:57Z","timestamp":1779866637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unlocking the roles of plasma soluble T-cell immunoglobulin and mucin domain-containing protein 3 in kidney diseases: findings from native and allograft biopsy cohorts"],"prefix":"10.1186","volume":"7","author":[{"given":"Yamei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1059-7950","authenticated-orcid":false,"given":"Yunying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"1","key":"469_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"469_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1517\/14728222.11.8.1005","volume":"11","author":"DE Anderson","year":"2007","unstructured":"Anderson DE. TIM-3 as a therapeutic target in human inflammatory diseases. Expert Opin Ther Targets. 2007;11(8):1005\u20139. https:\/\/doi.org\/10.1517\/14728222.11.8.1005.","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"469_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ymthe.2021.12.013","volume":"30","author":"S Huang","year":"2022","unstructured":"Huang S, Liu D, Sun J, Zhang H, Zhang J, Wang Q, et al. Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-kappaB signaling pathway in CD4 T cells. Mol Ther. 2022;30(3):1227\u201338. https:\/\/doi.org\/10.1016\/j.ymthe.2021.12.013.","journal-title":"Mol Ther"},{"issue":"1","key":"469_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41419-025-07574-4","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Fang L, Su X, Zhang J, Xiong H, Yu H, et al. Macrophage miR-4524a-5p\/TBP promotes beta-TrCP -TIM3 complex activation and TGFbeta release and aggravates NAFLD-associated fibrosis. Cell Death Dis. 2025;16(1):315. https:\/\/doi.org\/10.1038\/s41419-025-07574-4.","journal-title":"Cell Death Dis"},{"issue":"6","key":"469_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1165\/rcmb.2019-0070OC","volume":"61","author":"Y Wang","year":"2019","unstructured":"Wang Y, Kuai Q, Gao F, Wang Y, He M, Zhou H, et al. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice. Am J Respir Cell Mol Biol. 2019;61(6):727\u201336. https:\/\/doi.org\/10.1165\/rcmb.2019-0070OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"469_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/cei.13126","volume":"193","author":"Y Guo","year":"2018","unstructured":"Guo Y, Zhang J, Lai X, Chen M, Guo Y. Tim-3 exacerbates kidney ischaemia\/reperfusion injury through the TLR-4\/NF-kappaB signalling pathway and an NLR-C4 inflammasome activation. Clin Exp Immunol. 2018;193(1):113\u201329. https:\/\/doi.org\/10.1111\/cei.13126.","journal-title":"Clin Exp Immunol"},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmet.2019.02.007","volume":"23","author":"H Yang","year":"2019","unstructured":"Yang H, Xie T, Li D, Du X, Wang T, Li C, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-kappaB\/TNF-alpha pathway. Mol Metab. 2019;23:24\u201336. https:\/\/doi.org\/10.1016\/j.molmet.2019.02.007.","journal-title":"Mol Metab"},{"issue":"1","key":"469_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41420-023-01519-6","volume":"9","author":"P Li","year":"2023","unstructured":"Li P, Li X, Wu W, Hou M, Yin G, Wang Z, et al. Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-\u03baB-mediated inflammation. Cell Death Discovery. 2023;9(1):218. https:\/\/doi.org\/10.1038\/s41420-023-01519-6.","journal-title":"Cell Death Discovery"},{"issue":"48","key":"469_CR9","doi-asserted-by":"publisher","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","volume":"288","author":"K M\u00f6ller-Hackbarth","year":"2013","unstructured":"M\u00f6ller-Hackbarth K, Dewitz C, Schweigert O, Trad A, Garbers C, Rose-John S, et al. A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3). J Biol Chem. 2013;288(48):34529\u201344. https:\/\/doi.org\/10.1074\/jbc.M113.488478.","journal-title":"J Biol Chem"},{"key":"469_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115445","volume":"209","author":"C Bailly","year":"2023","unstructured":"Bailly C, Thuru X, Goossens L, Goossens J-F. Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases. Biochem Pharmacol. 2023;209:115445. https:\/\/doi.org\/10.1016\/j.bcp.2023.115445.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"469_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101686","volume":"5","author":"C Chen","year":"2024","unstructured":"Chen C, Zhao F, Peng J, Zhao D, Xu L, Li H, et al. Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8(+) t cell exhaustion and anti-PD-1 resistance. Cell Rep Med. 2024;5(8):101686. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101686.","journal-title":"Cell Rep Med"},{"issue":"1","key":"469_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaci.2020.09.007","volume":"147","author":"T Ueland","year":"2021","unstructured":"Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, et al. Elevated plasma sTIM-3 levels in patients with severe COVID-19. J Allergy Clin Immunol. 2021;147(1):92\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2020.09.007.","journal-title":"J Allergy Clin Immunol"},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.intimp.2018.01.008","volume":"55","author":"YM Li","year":"2018","unstructured":"Li YM, Shi YY, Li Y, Yan L, Tang JT, Bai YJ, et al. Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: a cross-sectional study. Int Immunopharmacol. 2018;55:330\u20135. https:\/\/doi.org\/10.1016\/j.intimp.2018.01.008.","journal-title":"Int Immunopharmacol"},{"key":"469_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109710","volume":"115","author":"Y Li","year":"2023","unstructured":"Li Y, Bai Y, Zhang H, Li Y, Yan L, Wang X, et al. Decreased expression of ADAM10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients. Int Immunopharmacol. 2023;115:109710. https:\/\/doi.org\/10.1016\/j.intimp.2023.109710.","journal-title":"Int Immunopharmacol"},{"issue":"93","key":"469_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf2223","volume":"9","author":"KO Dixon","year":"2024","unstructured":"Dixon KO, Lahore GF, Kuchroo VK. Beyond T cell exhaustion: TIM-3 regulation of myeloid cells. Sci Immunol. 2024;9(93):eadf2223. https:\/\/doi.org\/10.1126\/sciimmunol.adf2223.","journal-title":"Sci Immunol"},{"issue":"4","key":"469_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11543","volume":"24","author":"L Chen","year":"2022","unstructured":"Chen L, Qin Y, Lin B, Yu X, Zheng S, Zhou X, et al. Clinical value of the sTim\u20113 level in chronic kidney disease. Exp Ther Med. 2022;24(4):606. https:\/\/doi.org\/10.3892\/etm.2022.11543.","journal-title":"Exp Ther Med"},{"issue":"7","key":"469_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41581-022-00564-1","volume":"18","author":"E Hoxha","year":"2022","unstructured":"Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022;18(7):466\u201378. https:\/\/doi.org\/10.1038\/s41581-022-00564-1.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"469_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","volume":"21","author":"CK Cheung","year":"2025","unstructured":"Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J. The pathogenesis of IgA nephropathy and implications for treatment. Nat Rev Nephrol. 2025;21(1):9\u201323. https:\/\/doi.org\/10.1038\/s41581-024-00885-3.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"469_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM-K Tang","year":"2019","unstructured":"Tang PM-K, Nikolic-Paterson DJ, Lan H-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144\u201358. https:\/\/doi.org\/10.1038\/s41581-019-0110-2.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"469_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12026-014-8550-z","volume":"60","author":"X Yang","year":"2014","unstructured":"Yang X, Hu Z, Xia X, Zhen J, Zhuang X, Peng T. Expression of human t cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients. Immunol Res. 2014;60(1):85\u201390. https:\/\/doi.org\/10.1007\/s12026-014-8550-z.","journal-title":"Immunol Res"},{"issue":"6","key":"469_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1189\/jlb.3HI0117-005RR","volume":"102","author":"D Zhao","year":"2017","unstructured":"Zhao D, Guo M, Liu B, Lin Q, Xie T, Zhang Q, et al. Frontline science: Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE. J Leukoc Biol. 2017;102(6):1313\u201322. https:\/\/doi.org\/10.1189\/jlb.3HI0117-005RR.","journal-title":"J Leukoc Biol"},{"key":"469_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105803","volume":"75","author":"YM Li","year":"2019","unstructured":"Li YM, Li Y, Yan L, Tang JT, Wu XJ, Bai YJ, et al. Assessment of serum Tim-3 and Gal-9 levels in predicting the risk of infection after kidney transplantation. Int Immunopharmacol. 2019;75:105803. https:\/\/doi.org\/10.1016\/j.intimp.2019.105803.","journal-title":"Int Immunopharmacol"},{"key":"469_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clinbiochem.2021.12.010","volume":"102","author":"L Yan","year":"2022","unstructured":"Yan L, Yang Y, Li YM, Fan JW, Wang XD, Bai YJ, et al. Soluble Tim-3\/Gal-9 as predictors of adverse outcomes after kidney transplantation: a cohort study. Clin Biochem. 2022;102:19\u201325. https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.12.010.","journal-title":"Clin Biochem"},{"issue":"3","key":"469_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","volume":"24","author":"M Naesens","year":"2024","unstructured":"Naesens M, Roufosse C, Haas M, Lefaucheur C, Mannon RB, Adam BA, et al. The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am J Transplant. 2024;24(3):338\u201349. https:\/\/doi.org\/10.1016\/j.ajt.2023.10.016.","journal-title":"Am J Transplant"},{"issue":"Pt 1","key":"469_CR25","first-page":"443","volume":"1","author":"J Churg","year":"1973","unstructured":"Churg J, Ehrenreich T. Membranous nephropathy. Perspect Nephrol Hypertens. 1973;1(Pt 1):443\u20138.","journal-title":"Perspect Nephrol Hypertens"},{"issue":"4","key":"469_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0046-8177(82)80221-9","volume":"13","author":"SM Lee","year":"1982","unstructured":"Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982;13(4):314\u201322. https:\/\/doi.org\/10.1016\/S0046-8177(82)80221-9.","journal-title":"Hum Pathol"},{"issue":"4","key":"469_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TWC Tervaert","year":"2010","unstructured":"Tervaert TWC, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363. https:\/\/doi.org\/10.1681\/ASN.2010010010.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"469_CR28","doi-asserted-by":"publisher","first-page":"9927","DOI":"10.18632\/aging.202748","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Yan L, Li Y, Wan Z, Bai Y, Wang X, et al. Development and validation of routine clinical laboratory data derived marker-based nomograms for the prediction of 5-year graft survival in kidney transplant recipients. Aging (Albany NY). 2021;13(7):9927\u201347. https:\/\/doi.org\/10.18632\/aging.202748.","journal-title":"Aging (Albany NY)"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00469-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:24:00Z","timestamp":1779866640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00469-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00469-6","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of West China Hospital of Sichuan University (No. 2023 (2237)) and written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}